{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:00:10Z","timestamp":1791633610575,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10096-025-05236-z","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T11:15:20Z","timestamp":1755170120000},"page":"2559-2568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In vitro antimicrobial activity and clinical use of trimethoprim-sulfamethoxazole for infections due to KPC-producing\u00a0Gram-negative pathogens: a review"],"prefix":"10.1007","volume":"44","author":[{"given":"Matthew E.","family":"Falagas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios S.","family":"Kontogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sargianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos A.","family":"Kakoullis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"issue":"3","key":"5236_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5694\/j.1326-5377.1964.tb128121.x","volume":"2","author":"RG Cooper","year":"1964","unstructured":"Cooper RG, Wald M (1964) Successful treatment of proteus septic\u00e6mia with a new drug, trimethoprim. Med J Aust 2(3):93\u201396. https:\/\/doi.org\/10.5694\/j.1326-5377.1964.tb128121.x","journal-title":"Med J Aust"},{"issue":"2","key":"5236_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1136\/jcp.21.2.202","volume":"21","author":"JH Darrell","year":"1968","unstructured":"Darrell JH, Garrod LP, Waterworth PM (1968) Trimethoprim: laboratory and clinical studies. J Clin Pathol 21(2):202\u2013209. https:\/\/doi.org\/10.1136\/jcp.21.2.202","journal-title":"J Clin Pathol"},{"issue":"Suppl","key":"5236_CR3","first-page":"56","volume":"45","author":"W Brumfitt","year":"1969","unstructured":"Brumfitt W, Faiers MC, Pursell RE, Reeves DS, Turnbull AR (1969) Bacteriological, pharmacological and clinical studies with trimethoprim-sulphonamide combinations with particular reference to the treatment of urinary infections. Postgrad Med J 45(Suppl):56\u201361","journal-title":"Postgrad Med J"},{"issue":"4","key":"5236_CR4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/archinte.163.4.402","volume":"163","author":"PA Masters","year":"2003","unstructured":"Masters PA, O\u2019Bryan TA, Zurlo J, Miller DQ, Joshi N (2003) Trimethoprim-sulfamethoxazole revisited. Arch Intern Med 163(4):402\u2013410. https:\/\/doi.org\/10.1001\/archinte.163.4.402","journal-title":"Arch Intern Med"},{"issue":"15","key":"5236_CR5","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1096\/fj.99-1037com","volume":"14","author":"EP Quinlivan","year":"2000","unstructured":"Quinlivan EP, McPartlin J, Weir DG, Scott J (2000) Mechanism of the antimicrobial drug trimethoprim revisited. FASEB J 14(15):2519\u20132524. https:\/\/doi.org\/10.1096\/fj.99-1037com","journal-title":"FASEB J"},{"issue":"Supplement3","key":"5236_CR6","doi-asserted-by":"publisher","first-page":"S433","DOI":"10.1093\/infdis\/128.Supplement_3.S433","volume":"128","author":"GH Hitchings","year":"1973","unstructured":"Hitchings GH (1973) Mechanism of action of trimethoprim-sulfamethoxazole\u2014I. J Infect Dis 128(Supplement3):S433\u2013S436. https:\/\/doi.org\/10.1093\/infdis\/128.Supplement_3.S433","journal-title":"J Infect Dis"},{"key":"5236_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2217\/fmb-2016-0216","volume":"12","author":"S Maraki","year":"2017","unstructured":"Maraki S, Vardakas KZ, Samonis G et al (2017) In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece. Future Microbiol 12:683\u2013693. https:\/\/doi.org\/10.2217\/fmb-2016-0216","journal-title":"Future Microbiol"},{"issue":"2","key":"5236_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s11255-010-9768-x","volume":"43","author":"E Mantadakis","year":"2011","unstructured":"Mantadakis E, Tsalkidis A, Panopoulou M et al (2011) Antimicrobial susceptibility of pediatric uropathogens in thrace, Greece. Int Urol Nephrol 43(2):549\u2013555. https:\/\/doi.org\/10.1007\/s11255-010-9768-x","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"5236_CR9","doi-asserted-by":"publisher","first-page":"e37375","DOI":"10.1371\/journal.pone.0037375","volume":"7","author":"G Samonis","year":"2012","unstructured":"Samonis G, Karageorgopoulos DE, Maraki S et al (2012) Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One 7(5):e37375. https:\/\/doi.org\/10.1371\/journal.pone.0037375","journal-title":"PLoS One"},{"issue":"2","key":"5236_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1179\/joc.2009.21.2.115","volume":"21","author":"G Pappas","year":"2009","unstructured":"Pappas G, Athanasoulia AP, Matthaiou DK, Falagas ME (2009) Trimethoprim-sulfamethoxazole for methicillin-resistant Staphylococcus aureus: a forgotten alternative? J Chemother 21(2):115\u2013126. https:\/\/doi.org\/10.1179\/joc.2009.21.2.115","journal-title":"J Chemother"},{"issue":"3","key":"5236_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ijantimicag.2015.04.002","volume":"46","author":"ME Falagas","year":"2015","unstructured":"Falagas ME, Vardakas KZ, Roussos NS (2015) Trimethoprim\/sulfamethoxazole for acinetobacter spp.: a review of current microbiological and clinical evidence. Int J Antimicrob Agents 46(3):231\u2013241. https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.04.002","journal-title":"Int J Antimicrob Agents"},{"key":"5236_CR12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jgar.2018.08.010","volume":"15","author":"DP Mohapatra","year":"2018","unstructured":"Mohapatra DP, Debata NK, Singh SK (2018) Extensively drug-resistant and pandrug-resistant gram-negative bacteria in a tertiary-care hospital in Eastern India: a 4-year retrospective study. J Glob Antimicrob Resist 15:246\u2013249. https:\/\/doi.org\/10.1016\/j.jgar.2018.08.010","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"5236_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ph18030402","volume":"18","author":"ME Elshobary","year":"2025","unstructured":"Elshobary ME, Badawy NK, Ashraf Y et al (2025) Combating antibiotic resistance: mechanisms, Multidrug-Resistant pathogens, and novel therapeutic approaches: an updated review. Pharmaceuticals (Basel) 18(3):402. https:\/\/doi.org\/10.3390\/ph18030402","journal-title":"Pharmaceuticals (Basel)"},{"issue":"17","key":"5236_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.21037\/atm.2016.09.14","volume":"4","author":"Y Cag","year":"2016","unstructured":"Cag Y, Caskurlu H, Fan Y, Cao B, Vahaboglu H (2016) Resistance mechanisms. Ann Transl Med 4(17):326. https:\/\/doi.org\/10.21037\/atm.2016.09.14","journal-title":"Ann Transl Med"},{"issue":"8","key":"5236_CR15","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1128\/aac.00107-16","volume":"60","author":"KM Kazmierczak","year":"2016","unstructured":"Kazmierczak KM, Biedenbach DJ, Hackel M et al (2016) Global dissemination of BlaKPC into bacterial species beyond Klebsiella pneumoniae and in vitro susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam. Antimicrob Agents Chemother 60(8):4490\u20134500. https:\/\/doi.org\/10.1128\/aac.00107-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5236_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/antibiotics12040658","volume":"12","author":"D Forero-Hurtado","year":"2023","unstructured":"Forero-Hurtado D, Corredor-Rozo ZL, Ruiz-Castellanos JS et al (2023) Worldwide dissemination of blaKPC gene by novel mobilization platforms in Pseudomonas aeruginosa: a systematic review. Antibiotics 12(4):658. https:\/\/doi.org\/10.3390\/antibiotics12040658","journal-title":"Antibiotics"},{"key":"5236_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jgar.2025.01.009","volume":"41","author":"L Brescini","year":"2025","unstructured":"Brescini L, D\u2019Achille G, Papalini C et al (2025) Clinical and molecular characteristics of KPC-producing Klebsiella pneumoniae bloodstream infections: results of a multicentre study. J Glob Antimicrob Resist 41:216\u2013223. https:\/\/doi.org\/10.1016\/j.jgar.2025.01.009","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"5236_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jinf.2019.06.014","volume":"79","author":"J Rodriguez-G\u00f3mez","year":"2019","unstructured":"Rodriguez-G\u00f3mez J, P\u00e9rez-Nadales E, Guti\u00e9rrez-Guti\u00e9rrez B et al (2019) Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: the impact of inappropriate empirical treatment. J Infect 79(3):245\u2013252. https:\/\/doi.org\/10.1016\/j.jinf.2019.06.014","journal-title":"J Infect"},{"issue":"7","key":"5236_CR19","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1093\/jac\/dkv086","volume":"70","author":"M Tumbarello","year":"2015","unstructured":"Tumbarello M, Trecarichi EM, De Rosa FG et al (2015) Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother 70(7):2133\u20132143. https:\/\/doi.org\/10.1093\/jac\/dkv086","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"5236_CR20","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1128\/aac.01633-10","volume":"55","author":"IE Robledo","year":"2011","unstructured":"Robledo IE, Aquino EE, V\u00e1zquez GJ (2011) Detection of the KPC gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii during a PCR-based nosocomial surveillance study in Puerto Rico. Antimicrob Agents Chemother 55(6):2968\u20132970. https:\/\/doi.org\/10.1128\/aac.01633-10","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"5236_CR21","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1128\/aac.00899-09","volume":"54","author":"IE Robledo","year":"2010","unstructured":"Robledo IE, Aquino EE, Sant\u00e9 MI et al (2010) Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother 54(3):1354\u20131357. https:\/\/doi.org\/10.1128\/aac.00899-09","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5236_CR22","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00203-020-02161-x","volume":"203","author":"B Bedeni\u0107","year":"2021","unstructured":"Bedeni\u0107 B, Sardeli\u0107 S, Bogdani\u0107 M et al (2021) Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates. Arch Microbiol 203(4):1825\u20131831. https:\/\/doi.org\/10.1007\/s00203-020-02161-x","journal-title":"Arch Microbiol"},{"issue":"5","key":"5236_CR23","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/jac\/dkp327","volume":"64","author":"A Endimiani","year":"2009","unstructured":"Endimiani A, DePasquale JM, Forero S et al (2009) Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J Antimicrob Chemother 64(5):1102\u20131110. https:\/\/doi.org\/10.1093\/jac\/dkp327","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"5236_CR24","first-page":"288","volume":"11","author":"A Ghasemnejad","year":"2019","unstructured":"Ghasemnejad A, Doudi M, Amirmozafari N (2019) The role of the BlaKPC gene in antimicrobial resistance of Klebsiella pneumoniae. Iran J Microbiol 11(4):288\u2013293","journal-title":"Iran J Microbiol"},{"key":"5236_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00314","author":"R Han","year":"2020","unstructured":"Han R, Shi Q, Wu S et al (2020) Dissemination of carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) among carbapenem-resistant Enterobacteriaceae isolated from adult and children patients in China. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2020.00314","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"5236_CR26","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.diagmicrobio.2013.03.032","volume":"76","author":"RM Kaiser","year":"2013","unstructured":"Kaiser RM, Castanheira M, Jones RN, Tenover F, Lynfield R (2013) Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007\u20132009 SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 76(3):356\u2013360. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.03.032","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"5236_CR27","doi-asserted-by":"publisher","first-page":"e0093422","DOI":"10.1128\/aac.00934-22","volume":"66","author":"JA Karlowsky","year":"2022","unstructured":"Karlowsky JA, Wise MG, Hackel MA, Pevear DC, Moeck G, Sahm DF (2022) Ceftibuten-Ledaborbactam activity against Multidrug-Resistant and Extended-Spectrum-\u03b2-Lactamase-Positive clinical isolates of enterobacterales from a 2018\u20132020 global surveillance collection. Antimicrob Agents Chemother 66(11):e0093422. https:\/\/doi.org\/10.1128\/aac.00934-22","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"5236_CR28","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/INF.0000000000002176","volume":"38","author":"LK Logan","year":"2019","unstructured":"Logan LK, Nguyen DC, Scaggs Huang FA et al (2019) A multi-centered case-case-control study of factors associated with Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae infections in children and young adults. Pediatr Infect Dis J 38(5):490. https:\/\/doi.org\/10.1097\/INF.0000000000002176","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"5236_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1177\/039463201302600325","volume":"26","author":"I Santino","year":"2013","unstructured":"Santino I, Bono S, Nuccitelli A, Martinelli D, Petrucci C, Alari A (2013) Microbiological and molecular characterization of extreme drug-resistant Carbapenemase-producing Klebsiella pneumoniae isolates. Int J Immunopathol Pharmacol 26(3):785\u2013790. https:\/\/doi.org\/10.1177\/039463201302600325","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"10","key":"5236_CR30","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.3390\/microorganisms11102537","volume":"11","author":"G Sorovou","year":"2023","unstructured":"Sorovou G, Schinas G, Pasxali A et al (2023) Epidemiology and resistance phenotypes of carbapenem-resistant Klebsiella pneumoniae in Corfu general hospital (2019\u20132022): a comprehensive time series analysis of resistance gene dynamics. Microorganisms 11(10):2537. https:\/\/doi.org\/10.3390\/microorganisms11102537","journal-title":"Microorganisms"},{"issue":"4","key":"5236_CR31","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.diagmicrobio.2015.04.002","volume":"82","author":"CP Tavares","year":"2015","unstructured":"Tavares CP, Pereira PS, de Marques E (2015) Molecular epidemiology of KPC-2\u2013producing Enterobacteriaceae (non\u2013Klebsiella pneumoniae) isolated from Brazil. Diagn Microbiol Infect Dis 82(4):326\u2013330. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.04.002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5236_CR32","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.2147\/IDR.S175584","volume":"11","author":"D Tian","year":"2018","unstructured":"Tian D, Pan F, Wang C, Sun Y, Zhang H (2018) Resistance phenotype and clinical molecular epidemiology of carbapenem-resistant. Infect Drug Resist 11:1935\u20131943. https:\/\/doi.org\/10.2147\/IDR.S175584","journal-title":"Infect Drug Resist"},{"issue":"10","key":"5236_CR33","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1089\/mdr.2020.0390","volume":"27","author":"WX Zhang","year":"2021","unstructured":"Zhang WX, Chen HY, Chen C et al (2021) Resistance phenotype and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae isolates in Shanghai. Microb Drug Resist 27(10):1312\u20131318. https:\/\/doi.org\/10.1089\/mdr.2020.0390","journal-title":"Microb Drug Resist"},{"issue":"2","key":"5236_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/microorganisms13020422","volume":"13","author":"R Filev","year":"2025","unstructured":"Filev R, Lyubomirova M, Bogov B et al (2025) Urinary tract infections caused by Klebsiella pneumoniae and prolonged treatment with trimethoprim\/sulfamethoxazole. Microorganisms 13(2):422. https:\/\/doi.org\/10.3390\/microorganisms13020422","journal-title":"Microorganisms"},{"issue":"2","key":"5236_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s15010-016-0968-x","volume":"45","author":"R Murri","year":"2017","unstructured":"Murri R, Fiori B, Spanu T et al (2017) Trimethoprim\u2013sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series. Infection 45(2):209\u2013213. https:\/\/doi.org\/10.1007\/s15010-016-0968-x","journal-title":"Infection"},{"key":"5236_CR36","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.2147\/IDR.S312183","volume":"14","author":"B Weng","year":"2021","unstructured":"Weng B, Zhang X, Hong W, Yan C, Gong X, Cai C (2021) A case of sepsis due to carbapenem-resistant klebsiella pneumoniae in an extremely low-birth weight infant treated with trimethoprim\u2013sulfamethoxazole. Infect Drug Resist 14:2321\u20132325. https:\/\/doi.org\/10.2147\/IDR.S312183","journal-title":"Infect Drug Resist"},{"issue":"2","key":"5236_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107237","volume":"64","author":"M Wang","year":"2024","unstructured":"Wang M, Hao M, Cui X, Liu M, Zhang C, Wang S (2024) Tracking emergence and outbreak of Klebsiella pneumoniae co-producing NDM-1 and KPC-2 after sulfamethoxazole-trimethoprim treatment: insights from genetic analysis. Int J Antimicrob Agents 64(2):107237. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107237","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"5236_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1089\/mdr.2018.0085","volume":"25","author":"J Su","year":"2019","unstructured":"Su J, Li D, Guo Q, Guo Y, Zheng Y, Xu X (2019) In vitro bactericidal activity of trimethoprim-sulfamethoxazole\/colistin combination against carbapenem-resistant Klebsiella pneumoniae clinical isolates. Microb Drug Resist 25(2):152\u2013156. https:\/\/doi.org\/10.1089\/mdr.2018.0085","journal-title":"Microb Drug Resist"},{"issue":"1","key":"5236_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkae380","volume":"80","author":"A Ishak","year":"2025","unstructured":"Ishak A, Mazonakis N, Spernovasilis N, Akinosoglou K, Tsioutis C (2025) Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice. J Antimicrob Chemother 80(1):1\u201317. https:\/\/doi.org\/10.1093\/jac\/dkae380","journal-title":"J Antimicrob Chemother"},{"key":"5236_CR40","doi-asserted-by":"publisher","first-page":"204993612091204","DOI":"10.1177\/2049936120912049","volume":"7","author":"M Bassetti","year":"2020","unstructured":"Bassetti M, Peghin M (2020) How to manage KPC infections. Ther Adv Infect Dis 7:2049936120912049. https:\/\/doi.org\/10.1177\/2049936120912049","journal-title":"Ther Adv Infect Dis"},{"key":"5236_CR41","doi-asserted-by":"publisher","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","volume":"7","author":"PD Tamma","year":"2024","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA (2024) Infectious diseases society of America 2024 guidance on the treatment of Antimicrobial-Resistant Gram-Negative infections. Clinical infectious diseases. Published Online August 7:ciae403. https:\/\/doi.org\/10.1093\/cid\/ciae403","journal-title":"Published Online August"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05236-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05236-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05236-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:04:57Z","timestamp":1763413497000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05236-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["5236"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05236-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"None to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency declarations"}}]}}